Fewer than 1% of docs sees bias in online CME, survey finds

Share this article:
A Medscape-sponsored survey of a million physicians participating in online CME found that fewer than 1% perceived bias, regardless of whether or not it was commercially supported.

Overall, 93.48% of the 1,064,642 respondents said didn't perceive bias in the CME they participated in, with another 5.89% expressing no opinion and only .63% saying they did sense bias. Of those participating in commercially-supported CME, .84% perceived bias, while .48% of those participating in non-commercially–supported CME sensed bias.

The survey asked participants to indicate whether they agreed or disagreed, strongly or not, with the statement “The activity was presented objectively and free of commercial bias.” The number of those strongly disagreeing was just .14% overall—.17% of those participating in commercially-supported CME and 11% of those taking part in non-commercially supported CME.

“If commercial support caused bias, our subgroup analysis of those who strongly disagreed would be expected to show a larger difference, not the smaller difference we observed,” wrote the study's authors.

The study appears in the September issue of The American Journal of Medicine. Its sponsor, WebMD's Medscape, is a leading provider of online CME, and data came from physicians taking part in online CME through the site. Of 1,621,647 physician participants, around 66% completed the survey
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.